Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about IONS
Recent news which mentions IONS
< Previous
1
2
3
4
5
Next >
3 Stocks to Buy Now Before They Become Tomorrow’s Trillion-Dollar Companies
December 27, 2023
Tickers
IONS
TSM
UNH
Tags
NASDAQ:IONS,NYSE:UNH,NYSE:TSM
TSM
Stocks to Buy
From
InvestorPlace
Pricing Projections And Market Potential For Ionis' Newly Approved Nerve Damage Drug - Analyst Sees Over $700M Potential
December 22, 2023
Tickers
ALNY
AZN
IONS
NEWS
Tags
ALNY
Large Cap
News
From
Benzinga
New Hope for Nerve Damage Patients as AstraZeneca/Ionis' Eplontersen Receives FDA Nod for Hereditary Amyloidosis Treatment
December 22, 2023
Tickers
AZN
IONS
NEWS
Tags
Market News
AZN
why it's moving
From
Benzinga
Ionis' Strategic Shift Praised by Analysts For Donidalorsen's Global Reach
December 19, 2023
Tickers
IONS
TAK
Tags
IONS
General
Briefs
From
Benzinga
Where Ionis Pharmaceuticals Stands With Analysts
November 17, 2023
Tickers
IONS
Tags
Market News
Benzinga
Analyst Ratings
From
Benzinga
Cathie Wood's Ark Invest Goes Shopping For Moderna Stock — Sells DraftKings Shares Amid Quarterly Rise In Revenue, EPS Beat
November 02, 2023
Tickers
ARKG
ARKK
ARKQ
DKNG
Tags
IONS
DraftKings
Moderna
From
Benzinga
Analyst Expectations for Ionis Pharmaceuticals's Future
October 23, 2023
Tickers
IONS
Tags
Market News
Benzinga
Analyst Ratings
From
Benzinga
Cathie Wood-Led Ark Invest Sells Over $6.5M Worth Of Tesla Stock, What's Going On?
October 17, 2023
Tickers
ARKG
ARKK
CRSP
EVS
Tags
ARK Invest
Tesla
Markets
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2023
September 29, 2023
Tickers
ABBV
ADBE
ADSK
AKAM
Tags
TXRH
INTU
FDX
From
Benzinga
Ionis-Roche Join Forces To Compete In Neurodegenerative Disease Space, Analyst Sees Short-Term Challenges
September 27, 2023
Tickers
ALNY
AZN
IONS
NVS
Tags
Benzinga
Biotech
Briefs
From
Benzinga
Analyst Expectations for Ionis Pharmaceuticals's Future
September 27, 2023
Tickers
IONS
Tags
Market News
Benzinga
Analyst Ratings
From
Benzinga
Why Ionis Pharmaceuticals Stock Popped Today
September 26, 2023
Tickers
IONS
Tags
Market News
why it's moving
IONS
From
Benzinga
Ionis Pharmaceuticals' Rare Metabolic Disorder Candidate Poised To Become New Standard Treatment, Study Shows Encouraging Action
September 26, 2023
Tickers
IONS
Tags
News
Briefs
Benzinga
From
Benzinga
The 7 Most Hated Stocks by Institutional Traders
September 20, 2023
Tickers
GS
IONS
LLY
PDD
Tags
TMUS
IONS
Market News
From
InvestorPlace
Hypertension Impacts 1.2B People - Alnylam's Gene Silencing Drug Candidate Hits the Mark in Phase 2 Study, Offering Hope
September 07, 2023
Tickers
ALNY
IONS
RHHBF
RHHBY
Tags
Health Care
Trading Ideas
ALNY
From
Benzinga
Cathie Wood Buys Shares Of Pacific Biosciences, Reduces Exposure To DraftKings And Genius Sports
August 07, 2023
Tickers
ACCD
ARKG
ARKK
ARKW
Tags
ARKK
ACCD
ARKG
From
Benzinga
Analyst Upgrades Ionis Pharmaceuticals To Buy Amid Key Pipeline Developments: Eplontersen And Donidalorsen Show Promising Outlook
July 31, 2023
Tickers
ALNY
AZN
IONS
Tags
News
Equities
ALNY
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 31, 2023
July 31, 2023
Tickers
A
ABR
ADBE
AIV
Tags
Analyst Ratings
OTLY
LUXH
From
Benzinga
Apple To Rally Over 12%? Here Are 10 Other Analyst Forecasts For Monday
July 31, 2023
Tickers
AAPL
ADBE
BAX
CMCSA
Tags
PAG
AAPL
GTLS
From
Benzinga
Biogen Reports New Spinraza Data In Atrophy Patients After Incomplete Response To Novartis' Treatment
July 03, 2023
Tickers
BIIB
IONS
NVS
Tags
General
Analyst Ratings
BIIB
From
Benzinga
Hereditary Angioedema Update Solidifies Intellia's Cell Therapy's Competitive Efficacy Profile: Analyst
June 12, 2023
Tickers
IONS
NTLA
Tags
General
IONS
Briefs
From
Benzinga
Analyst Creates Bullish Pitch On Ionis Pharmaceuticals Citing 'Strategic Pivot Underway'
June 07, 2023
Tickers
AZN
IONS
Tags
Movers
Biotech
Benzinga
From
Benzinga
Why Ionis Pharmaceutical Shares Are Trading Lower Wednesday
June 07, 2023
Tickers
IONS
Tags
why it's moving
IONS
Market News
From
Benzinga
Analyst Expectations for Ionis Pharmaceuticals's Future
June 07, 2023
Tickers
IONS
Tags
IONS
BZI/AAR
Analyst Ratings
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2023
May 04, 2023
Tickers
ABSI
BLDR
BLKB
CERE
Tags
CERE
Market News
DHT
From
Benzinga
Recap: Ionis Pharmaceuticals Q1 Earnings
May 03, 2023
Tickers
IONS
Tags
Market News
Earnings
Benzinga
From
Benzinga
Ionis Pharmaceuticals's Earnings Outlook
May 02, 2023
Tickers
IONS
Tags
Market News
Earnings
Benzinga
From
Benzinga
Biogen's Amyotrophic Lateral Sclerosis Drug Scores Conditional Approval From FDA
April 26, 2023
Tickers
BIIB
IONS
Tags
FDA
General
BIIB
From
Benzinga
FDA grants accelerated approval to Biogen treatment for rare form of ALS
April 25, 2023
Tickers
BIIB
IONS
Tags
IONS
BIIB
From
MarketWatch
What's Going On With Biogen Stock Tuesday?
April 25, 2023
Tickers
BIIB
IONS
Tags
IONS
why it's moving
BIIB
From
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.